Abstract
Background: Thousands of bioactive compounds are identified and isolated from the medicinal plants every year, of which many possess significant health benefits. However, the overwhelming majority of entities suffer from poor water solubility and membrane permeability that impedes them approaching the clinical stage.
Methods: Lipid nanoparticles have shown to be a versatile platform for advanced delivery of various therapeuticals, including the oral, topical and systemic routes. Lipid nanoparticles are able to significantly improve the oral bioavailability, pharmacokinetic profile, skin permeability, and ocular residence time of drugs, demonstrating considerable potential in pharmaceutical or medical practice.
Results: This article profoundly reviews important applications of lipid nanoparticles in active natural medicines. Special concerns focus on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for their training in the oral, intravenous, percutaneous and ocular drug delivery.
Conclusion: The survey shows that lipid nanoparticles are promising vehicles for the delivery of various natural actives and may address some intractable problems associated with delivery thereof.
Keywords: Lipid nanoparticles, solid lipid nanoparticles, nanostructured lipid carriers, drug delivery, natural medicines, bioactive compounds.
Current Pharmaceutical Design
Title:Lipid Nanoparticles for the Delivery of Active Natural Medicines
Volume: 23 Issue: 43
Author(s): Huijie Xing, Huan Wang, Baojian Wu and Xingwang Zhang*
Affiliation:
- Division of Pharmaceutics, College of Pharmacy, Jinan University, Guangzhou,China
Keywords: Lipid nanoparticles, solid lipid nanoparticles, nanostructured lipid carriers, drug delivery, natural medicines, bioactive compounds.
Abstract: Background: Thousands of bioactive compounds are identified and isolated from the medicinal plants every year, of which many possess significant health benefits. However, the overwhelming majority of entities suffer from poor water solubility and membrane permeability that impedes them approaching the clinical stage.
Methods: Lipid nanoparticles have shown to be a versatile platform for advanced delivery of various therapeuticals, including the oral, topical and systemic routes. Lipid nanoparticles are able to significantly improve the oral bioavailability, pharmacokinetic profile, skin permeability, and ocular residence time of drugs, demonstrating considerable potential in pharmaceutical or medical practice.
Results: This article profoundly reviews important applications of lipid nanoparticles in active natural medicines. Special concerns focus on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for their training in the oral, intravenous, percutaneous and ocular drug delivery.
Conclusion: The survey shows that lipid nanoparticles are promising vehicles for the delivery of various natural actives and may address some intractable problems associated with delivery thereof.
Export Options
About this article
Cite this article as:
Xing Huijie, Wang Huan, Wu Baojian and Zhang Xingwang *, Lipid Nanoparticles for the Delivery of Active Natural Medicines, Current Pharmaceutical Design 2017; 23 (43) . https://dx.doi.org/10.2174/1381612824666171128105853
DOI https://dx.doi.org/10.2174/1381612824666171128105853 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting the Wingless Signaling Pathway with Natural Compounds as Chemopreventive or Chemotherapeutic Agents
Current Pharmaceutical Biotechnology Imidazole Scaffold Based Compounds in the Development of Therapeutic Drugs
Current Topics in Medicinal Chemistry New Targets, New Agents, and the Evolving Phenomena of Drug Resistance in Cancer
Current Cancer Therapy Reviews Synthesis and Evaluation of Glycyrrhetic Acid-aromatic Hybrids as Anti-inflammatory Agents
Medicinal Chemistry Gut Microbiota Modulation and Mucosal Immunity: Focus on Rifaximin
Mini-Reviews in Medicinal Chemistry Meet Our Associate Editor:
Current Molecular Medicine Cancer Molecular Imaging: Radionuclide-Based Biomarkers of the Epidermal Growth Factor Receptor (EGFR)
Current Topics in Medicinal Chemistry Epigenetic Changes Induced by Green Tea Catechins a re Associated with Prostate Cancer
Current Molecular Medicine Interaction of Wharton's Jelly Derived Fetal Mesenchymal Cells with Tumor Cells
Current Stem Cell Research & Therapy Development of PET Probes for Cancer Imaging
Current Topics in Medicinal Chemistry Dihydropyrimidine Dehydrogenase Genotyping and Phenotyping for 5- Fluorouracil Dysmetabolism: Moving Towards Personalized Chemotherapy in Patients with Cancer
Current Pharmacogenomics and Personalized Medicine Obesity Associated Modulation of miRNA and Co-Regulated Target Transcripts in Human Adipose Tissue of Non-Diabetic Subjects
MicroRNA Fat Digestion and its Role in Appetite Regulation and Energy Balance -The Importance of Enterostatin and Tetrahydrolipstatin
Current Medicinal Chemistry - Central Nervous System Agents Anticancer Actions of Omega-3 Fatty Acids - Current State and Future Perspectives
Anti-Cancer Agents in Medicinal Chemistry Cytotoxicity and Toxicological Studies of <i>Artocarpus altilis</i> Extracts, Inducing Apoptosis and Cell Cycle Arrest via <i>CASPASE-3</i> and <i>CASPASE-8</i> Pathways against Human Breast MCF-7 Cells
Combinatorial Chemistry & High Throughput Screening Editorial [Hot Topic: Advanced Imagings of Wallerian Degeneration, Pancreatobiliary System, Uterine Cervical Cancer, Periventricular Leukomalacia, Living Cells as well as MR Contrast Agent and QC of SPECT/CT]
Current Medical Imaging In Silico Transcriptomic Analysis of the Chloride Intracellular Channels (CLIC) Interactome Identifies a Molecular Panel of Seven Prognostic Markers in Patients with Pancreatic Ductal Adenocarcinoma
Current Genomics Biopharmaceutic Classification System: A Scientific Framework for Pharmacokinetic Optimization in Drug Research
Current Drug Metabolism Cancer Prevention with Promising Natural Products: Mechanisms of Action and Molecular Targets
Anti-Cancer Agents in Medicinal Chemistry Targeting Histone Onco- Modifications Using Plant-Derived Products
Current Drug Targets